Please login to the form below

Not currently logged in
Email:
Password:

Gene editing

This page shows the latest Gene editing news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca officially opens new R&D facility in UK

AstraZeneca officially opens new R&D facility in UK

said. The Discovery Centre  will support AstraZeneca’s focus on specialised and precision medicines and foster the discovery and development of next-generation therapeutics, including nucleotide-based, gene-editing and cell

Latest news

More from news
Approximately 7 fully matching, plus 56 partially matching documents found.

Latest Intelligence

  • How early-stage clinical research is facilitating the new wave of personalised medicines How early-stage clinical research is facilitating the new wave of personalised medicines

    Lastly, gene editing is a hugely promising area for new drug development in which DNA is inserted, deleted, modified or replaced in a genome. ... One of these adaptations relates to patient enrolment. Whereas previously CROs were able to draw on a

  • Alzheimer’s: the search for a cure Alzheimer’s: the search for a cure

    gene-editing specialist Sangamo for rights to tau-targeting drug ST-501 as part of a broader R&D alliance. ... Such a shift has recently happened in the gene therapy space, which was a backwater pursued largely by biotech until the progress of companies

  • Novo Nordisk awakens its ‘Sleeping Beauty’ Novo Nordisk awakens its ‘Sleeping Beauty’

    The next phases were to enrich the pipeline with acquisitions and partnerships, including a headline deal with blue-bird bio for next generation gene editing that could lead to a potential ... We also have a stem cell platform, gene editing, an exquisite

  • It started with a miss It started with a miss

    There are huge implications for communications. Take gene editing, for example. ... We’re going to get to the point where treatments like gene therapies will be ubiquitous – so we need to set ourselves up for them now and embrace the ethical debate

  • Bluebird: on a mission to ‘recode’ the DNA of healthcare Bluebird: on a mission to ‘recode’ the DNA of healthcare

    Europe is the test ground for the gene therapy pioneer’s outcomes-based model, which could set the standard for the emerging sector. ... These include pipeline gene-editing therapies from Sanofi and luspatercept from Celgene to name but a few, although

More from intelligence
Approximately 2 fully matching, plus 15 partially matching documents found.

Latest appointments

  • Eric Rhodes becomes CEO of ERS Genomics Eric Rhodes becomes CEO of ERS Genomics

    In these roles, Rhodes was responsible for commercialising the company's genome editing technologies as well as driving its research and development. ... Biosciences. Foy said: “With his deep understanding of the gene-editing landscape and extensive

  • Marc Becker joins CRISPR Therapeutics Marc Becker joins CRISPR Therapeutics

    He becomes chief financial officer. CRISPR Therapeutics has appointed Marc Becker as its new chief financial officer with remit to drive development of its gene-editing technology platform.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical website. Support the...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...